LNLaura Sperandio Nascimento

Laura Sperandio Nascimento

*This is an algorithmically generated author record based on publicly available information.

Laura Sperandio Nascimento has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Representações Sociais da Gravidez na Adolescência no Contexto da Atenção Primária em Saúde

    by Gabriella Bayer Baldo, Laura Sperandio Nascimento, Suelen Mayara Hartwig, Larissa Martelete Tiussi, Julia Lima Marino, Fabiana de Souza Mattos, Érica dos Santos Silva, Adriene de Freitas Moreno Rodrigues

    O estudo tem como objetivo avaliar as representações sociais da gravidez na adolescência na atenção primária à saúde, de um município do Espírito Santo, tendo como público-alvo adolescentes que vivenciavam a gestação. Tratou-se de um estudo observacional, descritivo, transversal, de abordagem qualitativa, tendo como base a Teoria geral das Representações Sociais. Os resultados principais concentraram-se nas evocações amor e responsabilidade, provavelmente relacionados ao contexto cultural e religioso. Portanto, para a compreensão desse evento é necessário se aprofundar na trajetória particular de cada jovem, sendo indispensável, evidenciar a necessidade de estratégias públicas que promovam a educação sexual.

  • Lipid profile and risk of cardiovascular disease in adult transgender men receiving cross-sex hormone therapy: a systematic review

    by Fernanda Cristina de Abreu Quintela-Castro, Taísa Sabrina Silva Pereira, Danúbia Boy Alves, Letícia Chiepe, Laura Sperandio Nascimento, Kelly Cristina Mota Braga Chiepe, Rafael Mazioli Barcelos, Bruno Maia Costa, Oscar Geovanny Enriquez-Martinez, Joamyr Victor Rossoni, et al.

    Context: A recent US national survey of the health status of the male transgender population has raised awareness about the little-studied relationship between testosterone hormone therapy in transgender men and cardiovascular outcomes. Objective: The aim of this systematic review was to assess the relationship between cross-sex hormone therapy in transgender men and lipid profiles and cardiovascular risk. Data Sources: The PubMed, SciELO, SpringerLink, and EBSCOhost databases were searched up to March 2021 for studies assessing the association between cross-sex hormone therapy and the incidence of outcomes related to cardiovascular disease in transgender men over 18 years of age . Data Extraction: Data extracted were sorted into clinical data (systolic, diastolic, and mean blood pressure), anthropometric data (body mass index, weight, waist circumference, fat mass, and lean mass), and biochemical data (triglycerides, total cholesterol, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], very low-density lipoprotein cholesterol [VLDL-C], and the HDL-C to LDL-C ratio). Data Analysis: Study quality was appraised independently by two reviewers using the Cochrane tools for assessment of methodological quality or risk of bias in nonrandomized studies, and the Newcastle-Ottawa Scale was applied. Of 735 studies identified, 11 were included in the review. Most studies reported no change in cholesterol or triglyceride levels after hormone treatment. A reduction in HDL-C levels was observed in 7 of 11 studies, although this alone cannot be considered a cardiovascular risk factor. Likewise, clinical and anthropometric findings showed no changes predictive of cardiovascular risk. Conclusions: Although these findings suggest that hormone therapy may lead to a decrease in HDL-C levels and an increase in LDL-C levels, they are insufficient to establish a relationship with cardiovascular disease. Furthermore, no significant effects on metabolic and anthropometric values were found. Further studies with higher quality and longer follow-up periods are needed to establish cardiovascular risk. Systematic Review Registration: PROSPERO registration number CRD 42020212560.